Relay Therapeutics, Inc. (RLAY) Executive Compensation
Relay Therapeutics, Inc. (RLAY) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: RLAY
CIK: 1812364
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2019 12:00:00 AM
Lead Engagement PartnerKimberly Reinert
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-08 | 2026-10-07 | 4 | 0001193125-26-418096 | View SEC Doc Filr Page |
| 4 | 2026-10-08 | 2026-10-06 | 4 | 0001193125-26-418094 | View SEC Doc Filr Page |
| 144 | 2026-10-07 | — | 144 Filing | 0001950047-26-010107 | View SEC Doc Filr Page |
| 144 | 2026-10-06 | — | 144 Filing | 0001950047-26-010071 | View SEC Doc Filr Page |
| 4 | 2026-09-09 | 2026-09-08 | 4 | 0001193125-26-386473 | View SEC Doc Filr Page |
| 4 | 2026-09-09 | 2026-09-08 | 4 | 0001193125-26-386464 | View SEC Doc Filr Page |
| 4 | 2026-09-09 | 2026-09-08 | 4 | 0001193125-26-386455 | View SEC Doc Filr Page |
| 4 | 2026-08-28 | 2026-08-26 | 4 | 0001193125-26-374645 | View SEC Doc Filr Page |
| 4 | 2026-08-28 | 2026-08-25 | 4 | 0001493152-26-040513 | View SEC Doc Filr Page |
| 144 | 2026-08-26 | — | 144 Filing | 0001950047-26-008711 | View SEC Doc Filr Page |
| 144 | 2026-08-25 | — | 144 Filing | 0001493152-26-040137 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-17 | 4 | 0001193125-26-355502 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-14 | 4 | 0001193125-26-355493 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001831942-26-000036 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-10 | — | SCHEDULE 13G/A Filing | 0001193125-26-342308 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-07 | — | SCHEDULE 13G/A Filing | 0000315066-26-002255 | View SEC Doc Filr Page |
| 424B5 | 2026-08-06 | — | 424B5 | 0001193125-26-338292 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001193125-26-338056 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | 8-K | 0001193125-26-338013 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-06 | — | SCHEDULE 13G Filing | 0000315066-26-002113 | View SEC Doc Filr Page |
| 144 | 2026-08-04 | — | 144 Filing | 0001950047-26-007601 | View SEC Doc Filr Page |
| 144 | 2026-07-31 | — | 144 Filing | 0001950047-26-007457 | View SEC Doc Filr Page |
| 4 | 2026-07-30 | 2026-07-28 | 4 | 0001193125-26-326144 | View SEC Doc Filr Page |
| 4 | 2026-07-30 | 2026-07-28 | 4 | 0001193125-26-326142 | View SEC Doc Filr Page |
| 4 | 2026-07-30 | 2026-07-28 | 4 | 0001193125-26-326137 | View SEC Doc Filr Page |